2025
SJR Q1
JCR Q1 · 5,6
OA
3 matched articles
SCIE
Journal detail
Stem Cell Reports
- Publisher
- Cell Press
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
22136711
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 2,038
- Quartile Q1
- H-Index 127
- Cites/doc 4,7
- Docs (3y) 506
- Cites (3y) 2.401
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 5,6
- 5Y JIF 5,8
- JCI 1
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Biochemistry Q1
- Cell Biology Q1
- Developmental Biology Q1
- Genetics Q1
Areas
- Biochemistry, Genetics and Molecular Biology
WoS categories
- Cell & Tissue Engineering | Cell Biology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 2,038 | 5,6 | 5,8 | 1 | Q1 | 127 |
| 2024 | Q1 | Q1 | 2,314 | 5,1 | 5,8 | 1,15 | Q1 | 120 |
| 2023 | Q1 | Q1 | 2,518 | 5,9 | 5,9 | 1,18 | Q1 | 120 |
| 2022 | Q1 | Q2 | 2,464 | 5,9 | 6,7 | 1,24 | Q1 | 120 |
| 2021 | Q1 | Q2 | 2,46 | 7,3 | 7,8 | 1,27 | Q1 | 120 |
| 2020 | Q1 | Q1 | 3,207 | 7,8 | 7,9 | 1,37 | Q1 | 120 |
| 2019 | Q1 | Q1 | 3,201 | 6 | 6,6 | 1,33 | Q1 | 120 |
| 2018 | — | Q1 | — | 5,5 | 6,6 | 1,35 | Q1 | — |
| 2017 | Q1 | Q1 | 5 | 6,5 | 7,2 | 1,51 | Q1 | 120 |
| 2016 | Q1 | Q1 | 5,489 | 7,3 | 7,5 | — | — | 120 |
| 2015 | Q1 | Q1 | 5,578 | 7 | 7 | — | — | 120 |
| 2014 | Q1 | Q1 | 5,123 | 5,4 | 5,4 | — | — | 120 |
| 2013 | — | — | — | — | — | — | — | 120 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | CELL BIOLOGY | SCIE | Q2 | Q2 | 68/207 |
| 2025 | CELL & TISSUE ENGINEERING | SCIE | Q1 | Q1 | 7/32 |
| 2024 | CELL BIOLOGY | SCIE | Q2 | Q1 | 60/204 |
| 2024 | CELL & TISSUE ENGINEERING | SCIE | Q1 | Q1 | 6/32 |
| 2023 | CELL BIOLOGY | SCIE | Q2 | Q1 | 55/205 |
| 2023 | CELL & TISSUE ENGINEERING | SCIE | Q1 | Q2 | 6/31 |
| 2022 | CELL BIOLOGY | SCIE | Q2 | Q1 | 61/191 |
| 2022 | CELL & TISSUE ENGINEERING | SCIE | Q2 | Q2 | 8/29 |
| 2021 | CELL BIOLOGY | SCIE | Q2 | Q1 | 56/195 |
| 2021 | CELL & TISSUE ENGINEERING | SCIE | Q2 | Q1 | 8/29 |
| 2020 | CELL BIOLOGY | SCIE | Q1 | Q1 | 41/195 |
| 2020 | CELL & TISSUE ENGINEERING | SCIE | Q1 | Q1 | 5/29 |
| 2019 | CELL BIOLOGY | SCIE | Q1 | Q1 | 44/195 |
| 2019 | CELL & TISSUE ENGINEERING | SCIE | Q1 | Q1 | 6/29 |
| 2018 | CELL BIOLOGY | SCIE | Q1 | Q1 | 43/193 |
| 2018 | CELL & TISSUE ENGINEERING | SCIE | Q1 | Q1 | 5/26 |
| 2017 | CELL BIOLOGY | SCIE | Q1 | Q1 | 34/190 |
| 2017 | CELL & TISSUE ENGINEERING | SCIE | Q1 | Q1 | 3/24 |
| 2016 | CELL BIOLOGY | SCIE | Q1 | — | 31/190 |
| 2016 | CELL & TISSUE ENGINEERING | SCIE | Q1 | — | 3/21 |
| 2015 | CELL BIOLOGY | SCIE | Q1 | — | 30/187 |
| 2015 | CELL & TISSUE ENGINEERING | SCIE | Q1 | — | 2/21 |
| 2014 | CELL BIOLOGY | SCIE | Q1 | — | 43/184 |
| 2014 | CELL & TISSUE ENGINEERING | SCIE | Q1 | — | 4/21 |